Key result
Molecular diagnostic technologies, including PCR, next-generation sequencing, and CRISPR-Cas, are critical tools for the early identification and management of emerging viral infectious diseases.
Why the study?
Emerging viral infectious diseases represent a constant threat to global public health, highlighting the need for molecular diagnostics to manage them.
Molecular diagnostics, including PCR, NGS, and CRISPR-Cas, play a critical role in the detection and management of emerging viral infectious diseases.
PCR central to viral detection; Level 5 evidence leaves comparative performance open for validation.
Emerging viral infectious diseases have been a constant threat to global public health in recent times. In managing these diseases, molecular diagnostics has played a critical role. Molecular diagnostics involves the use of various technologies to detect the genetic material of various pathogens, including viruses, in clinical samples. One of the most commonly used molecular diagnostics technologies for detecting viruses is polymerase chain reaction (PCR). PCR amplifies specific regions of the viral genetic material in a sample, making it easier to detect and identify viruses. PCR is particularly useful for detecting viruses that are present in low concentrations in clinical samples, such as blood or saliva. Another technology that is becoming increasingly popular for viral diagnostics is next-generation sequencing (NGS). NGS can sequence the entire genome of a virus present in a clinical sample, providing a wealth of information about the virus, including its genetic makeup, virulence factors, and potential to cause an outbreak. NGS can also help identify mutations and discover new pathogens that could affect the efficacy of antiviral drugs and vaccines. In addition to PCR and NGS, there are other molecular diagnostics technologies that are being developed to manage emerging viral infectious diseases. One of these is CRISPR-Cas, a genome editing technology that can be used to detect and cut specific regions of viral genetic material. CRISPR-Cas can be used to develop highly specific and sensitive viral diagnostic tests, as well as to develop new antiviral therapies. In conclusion, molecular diagnostics tools are critical for managing emerging viral infectious diseases. PCR and NGS are currently the most commonly used technologies for viral diagnostics, but new technologies such as CRISPR-Cas are emerging. These technologies can help identify viral outbreaks early, track the spread of viruses, and develop effective antiviral therapies and vaccines.
No takes yet. Share an insight, caveat, or question.
Altındiş et al. (2023) conducted a review in Viral emerging infectious diseases. Molecular diagnostics (PCR, NGS, CRISPR-Cas) was evaluated. Molecular diagnostic technologies, including PCR, next-generation sequencing, and CRISPR-Cas, are critical tools for the early identification and management of emerging viral infectious diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: